Chemical Space Overlap with Critical Protein–Protein Interface Residues in Commercial and Specialized Small‐Molecule Libraries
暂无分享,去创建一个
[1] Stuart L. Schreiber,et al. Chemical probes and drug leads from advances in synthetic planning and methodology , 2018, Nature Reviews Drug Discovery.
[2] S. Meroueh,et al. Mimicking Intermolecular Interactions of Tight Protein–Protein Complexes for Small‐Molecule Antagonists , 2017, ChemMedChem.
[3] Samy O Meroueh,et al. A Computational Investigation of Small-Molecule Engagement of Hot Spots at Protein-Protein Interaction Interfaces , 2017, J. Chem. Inf. Model..
[4] S. Meroueh,et al. Small Molecules Engage Hot Spots through Cooperative Binding To Inhibit a Tight Protein-Protein Interaction. , 2017, Biochemistry.
[5] Paul D Leeson,et al. Molecular inflation, attrition and the rule of five. , 2016, Advanced drug delivery reviews.
[6] H. Willems,et al. Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery. , 2016, Journal of medicinal chemistry.
[7] D. Scott,et al. Small molecules, big targets: drug discovery faces the protein–protein interaction challenge , 2016, Nature Reviews Drug Discovery.
[8] Min Liu,et al. Re-engineering the Immune Response to Metastatic Cancer: Antibody-Recruiting Small Molecules Targeting the Urokinase Receptor. , 2016, Angewandte Chemie.
[9] John J. Irwin,et al. ZINC 15 – Ligand Discovery for Everyone , 2015, J. Chem. Inf. Model..
[10] Olivier Sperandio,et al. iPPI-DB: an online database of modulators of protein–protein interactions , 2015, Nucleic Acids Res..
[11] Florent Chevillard,et al. SCUBIDOO: A Large yet Screenable and Easily Searchable Database of Computationally Created Chemical Compounds Optimized toward High Likelihood of Synthetic Tractability , 2015, J. Chem. Inf. Model..
[12] Jeremy R. Duvall,et al. Utilizing diversity-oriented synthesis in antimicrobial drug discovery. , 2014, Future medicinal chemistry.
[13] J. Wells,et al. Small-molecule inhibitors of protein-protein interactions: progressing toward the reality. , 2014, Chemistry & biology.
[14] Jean-Luc Poyet,et al. Drug-Like Protein–Protein Interaction Modulators: Challenges and Opportunities for Drug Discovery and Chemical Biology , 2014, Molecular informatics.
[15] Tom L. Blundell,et al. TIMBAL v2: update of a database holding small molecules modulating protein–protein interactions , 2013, Database J. Biol. Databases Curation.
[16] M. Congreve,et al. Ask the experts: past, present and future of the rule of five. , 2013, Future medicinal chemistry.
[17] Woody Sherman,et al. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments , 2013, Journal of Computer-Aided Molecular Design.
[18] L. Lam,et al. ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets , 2013, Nature Medicine.
[19] Jason E. Gestwicki,et al. Features of protein–protein interactions that translate into potent inhibitors: topology, surface area and affinity , 2012, Expert Reviews in Molecular Medicine.
[20] David R Spring,et al. Diversity-oriented synthesis: producing chemical tools for dissecting biology. , 2012, Chemical Society reviews.
[21] Jing Li,et al. Targeting multiple conformations leads to small molecule inhibitors of the uPAR·uPA protein-protein interaction that block cancer cell invasion. , 2011, ACS chemical biology.
[22] Jan H. Jensen,et al. PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKa Predictions. , 2011, Journal of chemical theory and computation.
[23] Sivaraman Dandapani,et al. Grand challenge commentary: Accessing new chemical space for 'undruggable' targets. , 2010, Nature chemical biology.
[24] Nathan T. Ross,et al. An aldol-based build/couple/pair strategy for the synthesis of medium- and large-sized rings: discovery of macrocyclic histone deacetylase inhibitors. , 2010, Journal of the American Chemical Society.
[25] Jonathan G. Lees,et al. Transient protein-protein interactions: structural, functional, and network properties. , 2010, Structure.
[26] Woody Sherman,et al. Analysis and comparison of 2D fingerprints: insights into database screening performance using eight fingerprint methods , 2010, J. Cheminformatics.
[27] Woody Sherman,et al. Large-Scale Systematic Analysis of 2D Fingerprint Methods and Parameters to Improve Virtual Screening Enrichments , 2010, J. Chem. Inf. Model..
[28] David Calkins,et al. Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution , 2010, J. Comput. Aided Mol. Des..
[29] Philippe Roche,et al. Atomic Analysis of Protein-Protein Interfaces with Known Inhibitors: The 2P2I Database , 2010, PloS one.
[30] Olivier Sperandio,et al. Designing Focused Chemical Libraries Enriched in Protein-Protein Interaction Inhibitors using Machine-Learning Methods , 2010, PLoS Comput. Biol..
[31] Fei Chen,et al. Structural insights into the YAP and TEAD complex. , 2010, Genes & development.
[32] W. Hong,et al. Structural basis of YAP recognition by TEAD4 in the hippo pathway. , 2010, Genes & development.
[33] Arthur J. Olson,et al. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..
[34] David R Spring,et al. Is synthesis the main hurdle for the generation of diversity in compound libraries for screening? , 2009, Expert opinion on drug discovery.
[35] Andreas Bender,et al. The discovery of antibacterial agents using diversity-oriented synthesis. , 2009, Chemical communications.
[36] Chong Li,et al. Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX , 2009, Proceedings of the National Academy of Sciences.
[37] Dima Kozakov,et al. Fragment-based identification of druggable 'hot spots' of proteins using Fourier domain correlation techniques , 2009, Bioinform..
[38] Solène Grosdidier,et al. Identification of hot-spot residues in protein-protein interactions by computational docking , 2008, BMC Bioinformatics.
[39] Adam Nelson,et al. Natural products as an inspiration in the diversity-oriented synthesis of bioactive compound libraries , 2008, Natural product reports.
[40] Andreas Bender,et al. Diversity-oriented synthesis; a spectrum of approaches and results. , 2008, Organic & biomolecular chemistry.
[41] Karl E Duderstadt,et al. Alanine-scanning mutagenesis defines a conserved energetic hotspot in the CaValpha1 AID-CaVbeta interaction site that is critical for channel modulation. , 2008, Structure.
[42] Jeremy R. Greenwood,et al. Epik: a software program for pKa prediction and protonation state generation for drug-like molecules , 2007, J. Comput. Aided Mol. Des..
[43] David E. Shaw,et al. PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results , 2006, J. Comput. Aided Mol. Des..
[44] Steven L Dixon,et al. PHASE: A Novel Approach to Pharmacophore Modeling and 3D Database Searching , 2006, Chemical biology & drug design.
[45] P. Hajduk,et al. Discovery of a potent inhibitor of the antiapoptotic protein Bcl-xL from NMR and parallel synthesis. , 2006, Journal of medicinal chemistry.
[46] Richard A. Friesner,et al. Integrated Modeling Program, Applied Chemical Theory (IMPACT) , 2005, J. Comput. Chem..
[47] Derek S. Tan,et al. Diversity-oriented synthesis: exploring the intersections between chemistry and biology , 2005, Nature chemical biology.
[48] Stephen J Haggarty,et al. The principle of complementarity: chemical versus biological space. , 2005, Current opinion in chemical biology.
[49] Paul D Leeson,et al. Time-related differences in the physical property profiles of oral drugs. , 2004, Journal of medicinal chemistry.
[50] B. Honig,et al. A hierarchical approach to all‐atom protein loop prediction , 2004, Proteins.
[51] Hege S. Beard,et al. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. , 2004, Journal of medicinal chemistry.
[52] Matthew P. Repasky,et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.
[53] J. Janin,et al. A dissection of specific and non-specific protein-protein interfaces. , 2004, Journal of molecular biology.
[54] David R Spring,et al. Diversity-oriented synthesis; a challenge for synthetic chemists. , 2003, Organic & biomolecular chemistry.
[55] Stephen R. Johnson,et al. Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.
[56] G. Weiss,et al. Rapid mapping of protein functional epitopes by combinatorial alanine scanning. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[57] A. Bogan,et al. Anatomy of hot spots in protein interfaces. , 1998, Journal of molecular biology.
[58] U. Weidle,et al. Systematic mutational analysis of the receptor-binding region of the human urokinase-type plasminogen activator. , 1996, European journal of biochemistry.
[59] Kyoung Tai No,et al. Natural products used as a chemical library for protein-protein interaction targeted drug discovery. , 2018, Journal of molecular graphics & modelling.
[60] C G M Wilson,et al. Small-molecule inhibitors of IL-2/IL-2R: lessons learned and applied. , 2011, Current topics in microbiology and immunology.